TickerFacts.

Bioharvest Sciences Inc. (BHST): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$1.62M
Year ended 2025-12-31
2023-12-31: $840.0K2024-12-31: $1.25M2025-12-31: $1.62M$1.62M
2023-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$1.62M+29.8%2026-03-31, From 2025-01-01
2024-12-31$1.25M+48.9%2026-03-31, From 2024-01-01
2023-12-31$840.0Kn/a2025-03-31, From 2023-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Bioharvest Sciences Inc. (BHST)2025-12-31$1.62M+29.8%
Earth Science Tech, Inc. (ETST)2026-03-31$284.4K+427.1%
Sunshine Biopharma Inc. (SBFM)2025-12-31$332.1K+48.6%
Lftd Partners Inc. (LIFD)2025-12-31$552.9K+6.2%
BGM Group Ltd. (BGM)2025-09-30$1.46M+18.3%
Foghorn Therapeutics Inc. (FHTX)2025-12-31$3.33M+6.8%
Biofrontera Inc. (BFRI)2025-12-31$138.0K-67.2%
Cue Biopharma, Inc. (CUE)2025-12-31$958.0K+141.3%
Xilio Therapeutics, Inc. (XLO)2025-12-31$1.54M-6.3%

Compare BHST, ETST, SBFM, LIFD side by side · Screen every company in Pharmaceutical Preparations ↗